Objective response (partial and complete) [clinicaltrials_resource:52ff4c4765e07c2ec52640d9ad558aa4]

Objective response (partial and complete) [clinicaltrials_resource:52ff4c4765e07c2ec52640d9ad558aa4]

Clinical trial summary from the National Cancer Institute's PDQ® database
clinicaltrials resource [clinicaltrials_vocabulary:Resource]
Secondary outcome [clinicaltrials_vocabulary:secondary-outcome]
http://bio2rdf.org/clinicaltrials_resource:52ff4c4765e07c2ec52640d9ad558aa4
Monoclonal Antibody With or Without gp100 Peptides Plus Montanide ISA-51 in Treating Patients With Stage IV Melanoma [clinicaltrials:NCT00077532]
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]

Objective response (partial and complete) [clinicaltrials_resource:52ff4c4765e07c2ec52640d9ad558aa4]

Clinical trial summary from the National Cancer Institute's PDQ® database
clinicaltrials resource [clinicaltrials_vocabulary:Resource]
Secondary outcome [clinicaltrials_vocabulary:secondary-outcome]
http://bio2rdf.org/clinicaltrials_resource:52ff4c4765e07c2ec52640d9ad558aa4
Bio2RDF identifier
52ff4c4765e07c2ec52640d9ad558aa4
Bio2RDF namespace
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:52ff4c4765e07c2ec52640d9ad558aa4
measure [clinicaltrials_vocabulary:measure]
Objective response (partial and complete)
description
Clinical trial summary from the National Cancer Institute's PDQ® database
identifier
clinicaltrials_resource:52ff4c4765e07c2ec52640d9ad558aa4
title
Objective response (partial and complete)
@en
inDataset
type
label
Objective response (partial an ...... f4c4765e07c2ec52640d9ad558aa4]
@en